FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2938589722> ?p ?o ?g. }

• W2938589722 endingPage "98" @default.
• W2938589722 startingPage "93" @default.
• W2938589722 abstract "Drug treatment for cancer has changed dramatically over the past decade with many new drugs often with multiple applications. More recently, the detailed pathway for approval from the National Institute for Health and Care Excellence (NICE) in the UK has been simplified. To explore how these changes have impacted on systemic anti-cancer therapy tumour site-specific prescribing and workload activities, we have reviewed the prescribing records for 2014-2018 in a UK cancer network.Information about the numbers of new systemic anti-cancer therapy drugs and NICE approvals were obtained from print editions of the British National Formulary (BNF) and the NICE website. Data on the numbers of new chemotherapy courses and individual treatment-related attendances were obtained from the cancer network Chemocare electronic prescribing system.During the five-year study period, there were 49 new systemic anti-cancer therapy drugs for all tumour types, and a total of 65 NICE technology approvals for solid tumour indications. Overall numbers of treatment courses increased by 40.7% and total treatment-related visits by 80.6%. There was a wide variation across tumour types with the highest number of increased visits seen for melanoma (349.3%) and prostate cancer (242.3%), but in contrast, no appreciable increases were seen for lower gastrointestinal cancers or small cell lung cancer.The study confirms the major impact of the arrival of new drug technology and positive NICE appraisals on increasing systemic anti-cancer therapy prescribing and chemotherapy unit activity. The data in this study may be of help in planning for future service delivery planning and workforce configurations." @default.
• W2938589722 created "2019-04-25" @default.
• W2938589722 creator A5020135002 @default.
• W2938589722 creator A5045606460 @default.
• W2938589722 creator A5075762990 @default.
• W2938589722 creator A5079718827 @default.
• W2938589722 creator A5080984611 @default.
• W2938589722 creator A5087114740 @default.
• W2938589722 creator A5091681745 @default.
• W2938589722 date "2019-04-07" @default.
• W2938589722 modified "2023-10-18" @default.
• W2938589722 title "The impact of new cancer drug therapies on site specialised cancer treatment activity in a UK cancer network 2014–2018" @default.
• W2938589722 cites W2042306244 @default.
• W2938589722 cites W2111285159 @default.
• W2938589722 cites W2151887932 @default.
• W2938589722 cites W2527905628 @default.
• W2938589722 cites W2552099557 @default.
• W2938589722 cites W2564342980 @default.
• W2938589722 cites W2587656541 @default.
• W2938589722 cites W2761792472 @default.
• W2938589722 doi "https://doi.org/10.1177/1078155219839445" @default.
• W2938589722 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30955466" @default.
• W2938589722 hasPublicationYear "2019" @default.
• W2938589722 type Work @default.
• W2938589722 sameAs 2938589722 @default.
• W2938589722 citedByCount "5" @default.
• W2938589722 countsByYear W29385897222020 @default.
• W2938589722 countsByYear W29385897222021 @default.
• W2938589722 countsByYear W29385897222022 @default.
• W2938589722 countsByYear W29385897222023 @default.
• W2938589722 crossrefType "journal-article" @default.
• W2938589722 hasAuthorship W2938589722A5020135002 @default.
• W2938589722 hasAuthorship W2938589722A5045606460 @default.
• W2938589722 hasAuthorship W2938589722A5075762990 @default.
• W2938589722 hasAuthorship W2938589722A5079718827 @default.
• W2938589722 hasAuthorship W2938589722A5080984611 @default.
• W2938589722 hasAuthorship W2938589722A5087114740 @default.
• W2938589722 hasAuthorship W2938589722A5091681745 @default.
• W2938589722 hasConcept C100406419 @default.
• W2938589722 hasConcept C111919701 @default.
• W2938589722 hasConcept C121608353 @default.
• W2938589722 hasConcept C126322002 @default.
• W2938589722 hasConcept C143998085 @default.
• W2938589722 hasConcept C17744445 @default.
• W2938589722 hasConcept C199360897 @default.
• W2938589722 hasConcept C199539241 @default.
• W2938589722 hasConcept C2776256026 @default.
• W2938589722 hasConcept C2777352838 @default.
• W2938589722 hasConcept C2777658100 @default.
• W2938589722 hasConcept C2778476105 @default.
• W2938589722 hasConcept C2779256446 @default.
• W2938589722 hasConcept C2780192828 @default.
• W2938589722 hasConcept C2780259306 @default.
• W2938589722 hasConcept C3020340455 @default.
• W2938589722 hasConcept C41008148 @default.
• W2938589722 hasConcept C502942594 @default.
• W2938589722 hasConcept C512399662 @default.
• W2938589722 hasConcept C526805850 @default.
• W2938589722 hasConcept C71924100 @default.
• W2938589722 hasConceptScore W2938589722C100406419 @default.
• W2938589722 hasConceptScore W2938589722C111919701 @default.
• W2938589722 hasConceptScore W2938589722C121608353 @default.
• W2938589722 hasConceptScore W2938589722C126322002 @default.
• W2938589722 hasConceptScore W2938589722C143998085 @default.
• W2938589722 hasConceptScore W2938589722C17744445 @default.
• W2938589722 hasConceptScore W2938589722C199360897 @default.
• W2938589722 hasConceptScore W2938589722C199539241 @default.
• W2938589722 hasConceptScore W2938589722C2776256026 @default.
• W2938589722 hasConceptScore W2938589722C2777352838 @default.
• W2938589722 hasConceptScore W2938589722C2777658100 @default.
• W2938589722 hasConceptScore W2938589722C2778476105 @default.
• W2938589722 hasConceptScore W2938589722C2779256446 @default.
• W2938589722 hasConceptScore W2938589722C2780192828 @default.
• W2938589722 hasConceptScore W2938589722C2780259306 @default.
• W2938589722 hasConceptScore W2938589722C3020340455 @default.
• W2938589722 hasConceptScore W2938589722C41008148 @default.
• W2938589722 hasConceptScore W2938589722C502942594 @default.
• W2938589722 hasConceptScore W2938589722C512399662 @default.
• W2938589722 hasConceptScore W2938589722C526805850 @default.
• W2938589722 hasConceptScore W2938589722C71924100 @default.
• W2938589722 hasIssue "1" @default.
• W2938589722 hasLocation W29385897221 @default.
• W2938589722 hasLocation W29385897222 @default.
• W2938589722 hasOpenAccess W2938589722 @default.
• W2938589722 hasPrimaryLocation W29385897221 @default.
• W2938589722 hasRelatedWork W2005886246 @default.
• W2938589722 hasRelatedWork W2081124398 @default.
• W2938589722 hasRelatedWork W2208441797 @default.
• W2938589722 hasRelatedWork W2215655489 @default.
• W2938589722 hasRelatedWork W2313809475 @default.
• W2938589722 hasRelatedWork W2979844924 @default.
• W2938589722 hasRelatedWork W3096611616 @default.
• W2938589722 hasRelatedWork W3168467091 @default.
• W2938589722 hasRelatedWork W3204224554 @default.
• W2938589722 hasRelatedWork W1674361436 @default.
• W2938589722 hasVolume "26" @default.
• W2938589722 isParatext "false" @default.
• W2938589722 isRetracted "false" @default.

• next